Diamant Thaҫi (Diamant Thaçi, D Thaçi, Diamant Thaci)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 68

Top Topics

Atopic Dermatitis

Top Venues

The British journal of dermatology

Dermatology and therapy

American journal of clinical dermatology

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Mark G Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials. The British journal of dermatology 190 (5) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy 14 (3) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy 14 (3) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy 14 (3) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Mark Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials. The British journal of dermatology (2024)
Brigitte Stephan, Stephan Jeff Rustenbach, Nesrine Ben-Anaya, Matthias Augustin, Wolf-Henning Boehncke, Michael Hertl, Ulrich Mrowietz, Petra Staubach-Renz, Diamant Thaҫi, Ralph Michael von Kiedrowski, Christina Sorbe
Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest. Journal of clinical medicine 13 (13) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy (2024)
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Johnathan Bar, Ronald Shore, Lori Ann Cox, Abigail Sloan, Diamant Thaҫi, Anand K Ganesan, George Han, Khaled Ezzedine, Zhan Ye, Emma Guttman-Yassky
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo. Archives of dermatological research 316 (7) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy (2024)
Brigitte Stephan, Stephan Jeff Rustenbach, Nesrine Ben-Anaya, Matthias Augustin, Wolf-Henning Boehncke, Michael Hertl, Ulrich Mrowietz, Petra Staubach-Renz, Diamant Thaҫi, Ralph Michael von Kiedrowski, Christina Sorbe
Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest. Journal of clinical medicine 13 (13) (2024)
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Johnathan Bar, Ronald Shore, Lori Ann Cox, Abigail Sloan, Diamant Thaҫi, Anand K Ganesan, George Han, Khaled Ezzedine, Zhan Ye, Emma Guttman-Yassky
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo. Archives of dermatological research 316 (7) (2024)
Jonathan Ian Silverberg, Melinda J Gooderham, Amy S Paller, Mette Deleuran, Christopher G Bunick, Linda F Stein Gold, Dirk-Jan Hijnen, Brian M Calimlim, Wan-Ju Lee, Henrique D Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M Platt, Diamant Thaҫi
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2). American journal of clinical dermatology 25 (3) (2024)
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Johnathan Bar, Ronald Shore, Lori Ann Cox, Abigail Sloan, Diamant Thaҫi, Anand K Ganesan, George Han, Khaled Ezzedine, Zhan Ye, Emma Guttman-Yassky
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo. Archives of dermatological research 316 (7) (2024)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Anja Plenske, Pascal Klaus, Thomas Meng
Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE. Rheumatology and therapy 11 (2) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy 14 (3) (2024)
Diamant Thaҫi, Andreas Pinter, Michael Sebastian, Christian Termeer, Michael Sticherling, Sascha Gerdes, Knut Schäkel, Sven Wegner, Stefanie Krampe, Holger Bartz, Christian Rausch, Friedemann Taut, Kilian Eyerich
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS). The British journal of dermatology 191 (1) (2024)
Henner Zirpel, Sascha Ständer, Alicja Frączek, Henning Olbrich, Ralf J Ludwig, Diamant Thaҫi
Atopic dermatitis is associated with an increased risk of cardiovascular diseases: A large-scale, propensity-matched US-based retrospective study. Clinical and experimental dermatology (2024)
Neil J Korman, Richard Bruce Warren, Jerry Bagel, April W Armstrong, Melinda J Gooderham, Bruce E Strober, Diamant Thaҫi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M Kisa, Subhashis Banerjee, Andrew Blauvelt
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. The Journal of dermatological treatment 35 (1) (2024)
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaҫi
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials. Dermatology and therapy 14 (3) (2024)
María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaҫi, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach-Renz, Ralph Michael von Kiedrowski, Matthias Augustin
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis (Auckland, N.Z.) 14 (2024)
Mark Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials. The British journal of dermatology (2024)
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Johnathan Bar, Ronald Shore, Lori Ann Cox, Abigail Sloan, Diamant Thaҫi, Anand K Ganesan, George Han, Khaled Ezzedine, Zhan Ye, Emma Guttman-Yassky
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo. Archives of dermatological research 316 (7) (2024)
Diamant Thaҫi, Andreas Pinter, Michael Sebastian, Christian Termeer, Michael Sticherling, Sascha Gerdes, Knut Schäkel, Sven Wegner, Stefanie Krampe, Holger Bartz, Christian Rausch, Friedemann Taut, Kilian Eyerich
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS). The British journal of dermatology 191 (1) (2024)
Henning Olbrich, Christian D Sadik, Ralf J Ludwig, Diamant Thaҫi, Katharina Boch
Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules 13 (4) (2023)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Correction: Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy (2023)
Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaҫi
Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy (2023)
Diamant Thaҫi, Ronald B Vender, Menno A de Rie, Curdin Conrad, David M Pariser, Bruce E Strober, Veerle Vanvoorden, Maggie Wang, Cynthia Madden, Dirk de Cuyper, Alexa B Kimball
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. The British journal of dermatology 188 (1) (2023)
Diamant Thaҫi, Andreas Pinter, Michael Sebastian, Chritsian Termeer, Michael Sticherling, Sascha Gerdes, Knut Schäkel, Sven Wegner, Stefanie Krampe, Holger Bartz, Christian Rausch, Friedemann Taut, Kilian Eyerich
Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS). The British journal of dermatology (2023)
Kenneth B Gordon, Richard G Langley, Richard Bruce Warren, Yukari Okubo, David Rosmarin, Mark Lebwohl, Luke Peterson, Cynthia Madden, Dirk de Cuyper, Owen Davies, Diamant Thaҫi
Bimekizumab safety in patients with moderate to severe plaque psoriasis: Pooled data from up to three years of treatment in randomized phase 3 trials. The British journal of dermatology (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Diamant Thaҫi, Andreas Pinter, Michael Sebastian, Chritsian Termeer, Michael Sticherling, Sascha Gerdes, Knut Schäkel, Sven Wegner, Stefanie Krampe, Holger Bartz, Christian Rausch, Friedemann Taut, Kilian Eyerich
Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS). The British journal of dermatology (2023)
A David Burden, Yukari Okubo, M Zheng, Diamant Thaҫi, Peter Cornelis Maria van de Kerkhof, N Hu, M Quaresma, C Thoma, Siew Eng Choon
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Experimental dermatology (2023)
Mark G Lebwohl, Joseph F Merola, Katelyn Rowland, Megan Miller, Ya-Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaҫi, Richard G Langley
Safety of Guselkumab Treatment for up to 5 Years in Patients With Moderate-to-Severe Psoriasis: Pooled Analyses Across Seven Clinical Trials With Greater Than 8600 Patient-Years of Exposure. The British journal of dermatology (2023)
Thomas Bieber, Norito Katoh, Eric L Simpson, Marjolein de Bruin-Weller, Diamant Thaҫi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P Thyssen
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials. The Journal of dermatological treatment 34 (1) (2023)
Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaҫi
Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 13 (3) (2023)
Diamant Thaҫi, Ronald B Vender, Menno A de Rie, Curdin Conrad, David M Pariser, Bruce E Strober, Veerle Vanvoorden, Maggie Wang, Cynthia Madden, Dirk de Cuyper, Alexa B Kimball
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. The British journal of dermatology 188 (1) (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Henning Olbrich, Christian D Sadik, Ralf J Ludwig, Diamant Thaҫi, Katharina Boch
Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules 13 (4) (2023)
Kim A Papp, Mark G Lebwohl, Diamant Thaҫi, Janusz Jaworski, Bartlomiej Kwiek, Jakub Trefler, Anna Dudek, Jacek Cezary Szepietowski, Nataliya Reznichenko, Joanna Narbutt, Wojciech Baran, Joanna Kolinek, Stefan Daniluk, Katarzyna Bartnicka-Maslowska, Adam Reich, Yuriy Andrashko, Sunghyun Kim, Yunju Bae, Dabee Jeon, Jinsun Jung, Hyunseung Lee, Tina Pyo, Woori Ko
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Andrew Blauvelt, Diamant Thaҫi, Kim A Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung-Kaung Shen, Yin You, Daphne Chan, Jenny Yu, Ya-Wen Yang, Mark G Lebwohl, Alice B Gottlieb, Jeffrey Crowley, Peter Foley
Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials. The British journal of dermatology (2023)
Henning Olbrich, Christian D Sadik, Ralf J Ludwig, Diamant Thaҫi, Katharina Boch
Dupilumab in Inflammatory Skin Diseases: A Systematic Review. Biomolecules 13 (4) (2023)
Nina Magnolo, Thomas Jaenicke, Athanasios Tsianakas, Wolfgang Czech, Diamant Thaҫi, Andreas Pinter, Delphine Kerob, Samir Salah, Thomas A Luger
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaҫi
Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 13 (3) (2023)
Johannes Griss, Gudrun Ratzinger, Julia-Tatjana Maul, Wolfgang Weger, Diamant Thaҫi, Y José Manuel Carrascosa, Constanze Jonak
No impact of disease duration on response to tildrakizumab treatment among patients with moderate-to-severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies. Skin health and disease 3 (5) (2023)
Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaҫi
Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 13 (3) (2023)
Alin Codrut Nicolescu, Marius-Anton Ionescu, Maria-Magdalena Constantin, Ioan Ancuta, Sinziana-Octavia Ionescu, Elena Niculeț, Alin Laurențiu Tatu, Henner Zirpel, Diamant Thaҫi
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness. Life (Basel, Switzerland) 12 (12) (2022)
Diamant Thaҫi, Dave Singh, Mark S Lee, Helen Timmis, Dominique Jacobs, Paul Passier, Susanne Rohrer, Johan Beetens, De Phung, Eric Sondag, Goran Babic, Guido Würth, Pia Kloepfer, Stefan Härtle, Silke Hüttner
Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis. Journal of clinical medicine 11 (23) (2022)
Alin Codrut Nicolescu, Marius-Anton Ionescu, Maria-Magdalena Constantin, Ioan Ancuta, Sinziana-Octavia Ionescu, Elena Niculeț, Alin Laurențiu Tatu, Henner Zirpel, Diamant Thaҫi
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness. Life (Basel, Switzerland) 12 (12) (2022)
Diamant Thaҫi, Andrea Bauer, Ralph von Kiedrowski, Florian Schenck, Konstantin Ertner, Sophie Möller, Anja Fait, Mike Bastian, Matthias Augustin
Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study. Dermatology and therapy 12 (9) (2022)
Alin Codrut Nicolescu, Marius-Anton Ionescu, Maria-Magdalena Constantin, Ioan Ancuta, Sinziana-Octavia Ionescu, Elena Niculeț, Alin Laurențiu Tatu, Henner Zirpel, Diamant Thaҫi
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness. Life (Basel, Switzerland) 12 (12) (2022)
James G Krueger, Lluis L Puig, Diamant Thaҫi
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis. American journal of clinical dermatology 23 (Suppl 1) (2022)
Alin Codrut Nicolescu, Marius-Anton Ionescu, Maria-Magdalena Constantin, Ioan Ancuta, Sinziana-Octavia Ionescu, Elena Niculeț, Alin Laurențiu Tatu, Henner Zirpel, Diamant Thaҫi
Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness. Life (Basel, Switzerland) 12 (12) (2022)
Diamant Thaҫi, Dave Singh, Mark S Lee, Helen Timmis, Dominique Jacobs, Paul Passier, Susanne Rohrer, Johan Beetens, De Phung, Eric Sondag, Goran Babic, Guido Würth, Pia Kloepfer, Stefan Härtle, Silke Hüttner
Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis. Journal of clinical medicine 11 (23) (2022)
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaҫi, Thilo Klopsch, Anja Plenske, Lisa K Blindzellner, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Rheumatology and therapy 9 (2) (2022)
Diamant Thaҫi, Dave Singh, Mark S Lee, Helen Timmis, Dominique Jacobs, Paul Passier, Susanne Rohrer, Johan Beetens, De Phung, Eric Sondag, Goran Babic, Guido Würth, Pia Kloepfer, Stefan Härtle, Silke Hüttner
Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis. Journal of clinical medicine 11 (23) (2022)
Gil Yosipovitch, Marjolein de Bruin-Weller, April W Armstrong, Jashin J Wu, Pedro Herranz Pinto, Diamant Thaҫi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana Beatris Rossi, Jingdong Chao
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 11 (6) (2021)
Diamant Thaҫi, Kilian Eyerich, Andreas Pinter, M Sebastian, K Unnebrink, S Rubant, D A Williams, P Weisenseel
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial. The British journal of dermatology (2021)
Andrew Blauvelt, April W Armstrong, Richard G Langley, Kurt Gebauer, Diamant Thaҫi, Jerry Bagel, Lyn C Guenther, Carle F Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hsu, Yin You, Kristian Reich
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. The Journal of dermatological treatment (2021)
Lisa A Beck, Diamant Thaҫi, Mette Deleuran, Marjolein de Bruin-Weller, Zhen Chen, Faisal A Khokhar, Meng Zhang, Zafer E Ozturk, Brad Shumel
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study. The Journal of dermatological treatment (2021)
Katrina Abuabara, Jonathan Ian Silverberg, Eric Lawrence Simpson, Amy S Paller, Lawrence F Eichenfield, Robert Bissonnette, James G Krueger, John E Harris, Laura Dalfonso, Stephanie E Watkins, Julie M Crawford, Diamant Thaҫi, Emma Guttman-Yassky
International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale. BMJ open 10 (11) (2020)